C. W. Ang, A. M. Jarrad, M. A. Cooper, and M. A. Blaskovich, Nitroimidazoles: Molecular Fireworks That Combat a Broad Spectrum of Infectious Diseases, J. Med. Chem, vol.60, pp.7636-7657, 2017.

S. Patterson and S. Wyllie, Nitro drugs for the treatment of trypanosomatid diseases: past, present, and future prospects, Trends Parasitol, vol.30, pp.289-298, 2014.

S. Wyllie, S. Patterson, and A. H. Fairlamb, Assessing the essentiality of leishmania donovani nitroreductase and its role in nitro drug activation, Antimicrob. Agents Chemother, vol.57, pp.901-906, 2013.

S. Wyllie, A. J. Roberts, S. Norval, S. Patterson, B. J. Foth et al., Activation of bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania, PLoS Pathog, vol.12, 2016.

B. S. Hall, C. Bot, and S. R. Wilkinson, Nifurtimox activation by trypanosomal type I nitroreductases generates cytotoxic nitrile metabolites, J. Biol. Chem, pp.286-13088, 2011.

B. S. Hall and S. R. Wilkinson, Activation of Benznidazole by trypanosomal type I nitroreductases results in glyoxal formation, Antimicrob. Agents Chemother, vol.56, pp.115-123, 2012.

P. Verhaeghe, P. Rathelot, S. Rault, and P. Vanelle, Convenient preparation of original vinylic chlorides with antiparasitic potential in quinolone series, Lett. Org. Chem, vol.3, pp.891-897, 2006.

L. Paloque, P. Verhaeghe, M. Casanova, C. Castera-ducros, A. Dumetre et al., Discovery of a new antileishmanial hit in 8-nitroquinoline series, Eur. J. Med. Chem, vol.54, pp.75-86, 2012.
URL : https://hal.archives-ouvertes.fr/hal-02049707

C. Kieffer, A. Cohen, P. Verhaeghe, S. Hutter, C. Castera-ducros et al., Looking for new antileishmanial derivatives in 8-nitroquinolin-2(1H)-one series, Eur. J. Med. Chem, vol.92, pp.282-294, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01460569

C. Kieffer, A. Cohen, P. Verhaeghe, L. Paloque, S. Hutter et al., Antileishmanial pharmacomodulation in 8-nitroquinolin-2(1H)-one series, Bioorg. Med. Chem, vol.23, pp.2377-2386, 2015.
URL : https://hal.archives-ouvertes.fr/hal-01460646

J. Pedron, C. Boudot, S. Hutter, S. Bourgeade-delmas, J. Stigliani et al., Novel 8-nitroquinolin-2(1H)-ones as NTR-bioactivated antikinetoplastid molecules: synthesis, electrochemical and SAR study, Eur. J. Med. Chem, vol.155, pp.135-152, 2018.
URL : https://hal.archives-ouvertes.fr/hal-01888465

J. Pedron, C. Boudot, S. Bourgeade-delmas, A. Sournia-saquet, L. Paloque et al., Antitrypanosomal pharmacomodulation at position 3 of the 8-nitroquinolin-2(1H)-one scaffold using pallado-catalyzed cross coupling reactions, vol.13, pp.2217-2228, 2018.

F. Zaragoza, H. Stephensen, and B. Peschke, Rimvall, K. 2-(4-alkylpiperazin-1-yl)quinolines as a new class of imidazole-free histamine H 3 receptor antagonists, J. Med. Chem, vol.48, pp.306-311, 2005.

N. J. O'brien, M. Brzozowski, D. J. Wilson, L. W. Deady, and B. M. Abbott, Synthesis and biological evaluation of substituted 3-anilinoquinolin-2(1H)-ones as PDK1 inhibitors, Bioorg. Med. Chem, vol.22, pp.3781-3790, 2014.

L. Di, E. H. Kerns, I. F. Bezar, S. L. Petusky, and Y. Huang, Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB, J. Pharm. Sci, vol.98, 1980.

J. P. Jourdan, M. Since, L. El-kihel, C. Lecoutey, S. Corvaisier et al., Benzylphenylpyrrolizinones with anti-amyloid and radical scavenging effects, potentially useful in Alzheimer's disease treatment, vol.12, pp.913-916, 2017.

H. Van-de-waterbeemd, G. Camenisch, G. Folkers, J. R. Chretien, and O. A. Raevsky, Estimation of blood-brain barrier crossing of drugs using molecular size and shape, and H-bonding descriptors, J. Drug Target, vol.6, pp.151-165, 1998.

T. T. Wager, X. Hou, P. R. Verhoest, and A. Villalobos, Moving beyond rules: the development of a central nervous system multiparameter optimization (CNS MPO) approach to enable alignment of druglike properties, ACS Chem. Neurosci, vol.1, pp.435-449, 2010.

K. Nepali, H. Lee, and J. Liou, Nitro-Group-Containing Drugs, J. Med. Chem, vol.62, pp.2851-2893, 2019.

E. J. Rosenkranz, E. C. Mccoy, R. Mermelstein, and H. S. Rosenkranz, Evidence for the existence of distinct nitroreductases in Salmonella typhimurium: roles in mutagenesis, Carcinogenesis, vol.3, pp.121-123, 1982.

E. Torreele, B. Bourdin-trunz, D. Tweats, M. Kaiser, R. Brun et al., Fexinidazole -a new oral nitroimidazole drug candidate entering clinical development for the treatment of sleeping sickness, PLoS Neglected Trop. Dis, vol.4, issue.e923, 2010.

J. Westland and F. Dorman, QuEChERS extraction of benzodiazepines in biological matrices, J. Pharm. Anal, vol.3, pp.509-517, 2013.

. Pkanalix, Data Processing and Calculation Rules, 2019.

K. Katsuno, J. N. Burrows, K. Duncan, R. H. Van-huijsduijnen, T. Kaneko et al., Hit and lead criteria in drug discovery for infectious diseases of the developing worlds, Nat. Rev. Drug Discovery, vol.14, 2015.

C. Zhang, S. Bourgeade-delmas, A. F. Alvarez, A. Valentin, C. Hemmert et al.,

, Synthesis, characterization, and antileishmanial activity of neutral N-heterocyclic carbenes gold(I) complexes, Eur. J. Med. Chem, vol.143, pp.1635-1643

S. Goyard, H. Segawa, J. Gordon, M. Showalter, R. Duncan et al., An in vitro system for developmental and genetic studies of Leishmania donovani phosphoglycans, Mol Biochem Parasitol, vol.130, pp.31-42, 2003.

S. Wyllie, A. J. Roberts, S. Norval, S. Patterson, B. J. Foth et al.,

A. H. Fairlamb, Activation of bicyclic nitro-drugs by a novel nitroreductase (NTR2) in Leishmania

, PLoS Pathog, 2016.

S. Wyllie, S. Patterson, L. Stojanovski, F. R. Simeons, S. Norval et al., The anti-trypanosome drug fexinidazole shows potential for treating visceral leishmaniasis, Sci. Transl. Med, 2012.

T. Baltz, D. Baltz, C. Giroud, and J. Crockett, Cultivation in a semi-defined medium of animal infective forms of T. brucei, T. equiperdum, T. evansi, T. rhodesiense and T. gambiense, EMBO J, vol.4, pp.1273-1277, 1985.

B. Räz, M. Iten, Y. Grether-bühler, and R. Kaminsky, The AlamarBlue ® Blue assay to determine drug sensitive of African trypanosome (T. brucei rhodesiense and T. brucei gambiense) in vitro, Acta Trop, vol.68, pp.139-147, 1997.

J. Guillon, A. Cohen, R. N. Das, C. Boudot, N. Gueddouda et al., , vol.2, p.9, 2018.

, Biol. Drug Des, vol.91, pp.974-995

N. Greig, S. Wyllie, S. Patterson, and A. H. Fairlamb, A comparative study of methylglyoxal metabolism in trypanosomatids, FEBS J, vol.276, pp.376-86, 2009.

S. Wyllie, B. J. Foth, A. Kelner, A. Y. Sokolova, M. Berriman et al., , 2016.

, Nitroheterocyclic drug resistance mechanisms in Trypanosoma brucei, J. Antimicrob. Chemother, vol.71, pp.625-659

D. C. Jones, I. Hallyburton, L. Stojanovski, K. D. Read, J. A. Frearson et al., Identification of a kappa-opioid agonist as a potent and selective lead for drug development against human African trypanosomiasis, Biochem. Pharmacol, vol.80, pp.1478-86, 2010.
URL : https://hal.archives-ouvertes.fr/hal-00626235

T. J. Mosman, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Meth, vol.65, pp.55-63, 1983.

H. Perdry, K. B. Gutzkow, M. Chevalier, L. Huc, G. Brunborg et al., Validation of Gelbond ® high-throughput alkaline and Fpg-modified comet assay using a linear mixed model, Environ. Mol. Mutagen, vol.59, pp.595-602, 2018.

J. P. Jourdan, M. Since, L. El-kihel, C. Lecoutey, S. Corvaisier et al., , 2017.

, Benzylphenylpyrrolizinones with anti-amyloid and radical scavenging effects, potentially useful in Alzheimer's disease treatment, ChemMedChem, vol.12, pp.913-916

D. L. Kerns, I. F. Bezar, S. L. Petusky, and Y. Huang, Comparison of blood-brain barrier permeability assays: in situ brain perfusion, MDR1-MDCKII and PAMPA-BBB, J. Pharm. Sci, vol.98, 1980.

C. Lecoutey, D. Hedou, T. Freret, P. Giannoni, F. Gaven et al.,

S. Corvaisier, A. Malzert-fréon, S. Mignani, T. Cresteil, M. Boulouard et al., Design of donecopride, a dual serotonin subtype 4 receptor agonist/acetylcholinesterase inhibitor with potential interest for Alzheimer's disease treatment, Proc, 2004.

, Natl. Acad. Sci. USA, vol.111

J. Westland and F. Dorman, QuEChERS extraction of benzodiazepines in biological matrices, 2013.

, J. Pharm. Anal, vol.3, pp.509-517

S. Dulaurent, S. Balkhi, L. Poncelet, J. M. Gaulier, P. Marquet et al., QuEChERS sample preparation prior to LC-MS/MS determination of opiates, amphetamines, and cocaine metabolites in whole blood, Anal. Bioanal. Chem, vol.408, pp.1467-1474, 2016.